Rays of Belief’s ungranted options total Rs 7.74 crore

Rays of Belief Limited recognised Rs 5.16 crore of cash and equity consideration for its June 23, 2025 US acquisition, while stock options equivalent to Rs 7.74 crore remained ungranted at March 31, 2026. The full option component depends on earnings before interest, tax, depreciation and amortisation, or EBITDA, targets over three years.

What did Rays of Belief pay for the US acquisition?

Rays of Belief acquired 100% of Mom's Belief US Inc. on June 23, 2025, and the acquired company in turn owns 100% of Allergy & Immunology LLC. The share purchase agreement described an aggregate contractual purchase price of Rs 12.90 crore, including cash, Rays of Belief equity shares and the performance-linked stock-option component.

Rays of Belief recognised Rs 5.16 crore as consideration transferred in the business-combination table. That amount comprised Rs 2.58 crore of cash paid at closing and Rs 2.58 crore of buyer equity shares issued as a rollover component, while the cash-flow statement recorded Rs 5.16 crore as the purchase of shares in the subsidiary during the year ended March 31, 2026.

Rays of Belief recognised Rs 4.53 crore of goodwill at the June 23, 2025 acquisition date because the Rs 5.16 crore recognised consideration exceeded Rs 0.63 crore of net identifiable assets acquired. Goodwill stood at Rs 4.99 crore on March 31, 2026 after a Rs 0.46 crore foreign-currency translation difference was recorded in other comprehensive income.

Why are Rays of Belief’s ungranted options worth Rs 7.74 crore?

Rays of Belief’s entire option component is performance-linked and was equivalent to Rs 7.74 crore using the acquisition-date exchange rate implied by the disclosed Rs 5.16 crore cash-and-equity consideration. The options are conditional on achievement of specified EBITDA targets over three years, so the selling shareholders do not become entitled to them merely because the acquisition closed on June 23, 2025.

The original agreement allocated Rs 1.42 crore of options to a time-linked component and Rs 6.32 crore to performance-linked options. A subsequent mutual letter of understanding converted the time-linked component into a performance-linked option, leaving the complete Rs 7.74 crore option component subject to the three-year EBITDA condition.

The ungranted option component was larger than the Rs 5.16 crore of recognised cash and equity consideration at March 31, 2026. That comparison does not establish that the options will be granted, because the outcome depends on undisclosed EBITDA targets; the disclosure does not provide the target values, annual milestones, option quantity or exercise conditions.

How did Rays of Belief account for the ungranted options?

Rays of Belief’s goodwill note says no amount was recognised for the ungranted performance-linked options as at March 31, 2026. The note says their classification was still being evaluated as either contingent consideration under Indian Accounting Standard 103, Business Combinations, or remuneration for post-combination services under Indian Accounting Standard 102, Share-based Payment.

The classification determines whether the option component is part of the acquisition accounting or payment for services after the June 23, 2025 transaction. The goodwill note states that information about facts existing at the acquisition date could create a measurement-period adjustment to goodwill, whereas changes arising from later performance outcomes would not adjust goodwill.

Rays of Belief also disclosed distinct subsequent treatments under Indian Accounting Standard 103. Liability-classified contingent consideration is remeasured through profit or loss, while equity-classified contingent consideration is not subsequently remeasured; both treatments depend on the eventual classification of the Rs 7.74 crore performance-linked component.

Do Rays of Belief’s audit and goodwill disclosures differ?

Yes, the disclosures describe different positions on whether a value for the ungranted options formed part of purchase consideration. The key audit matter says management estimated the acquisition-date fair value of the Rs 7.74 crore performance-linked option consideration for inclusion in purchase consideration, despite no independent valuation having been obtained.

The same key audit matter says the Indian Accounting Standard 103 measurement period ended on June 23, 2026 and that the purchase-price allocation, including contingent consideration, had been finalised. It further says a subsequent grant or change in the fair-value estimate would be accounted for without adjusting goodwill, except for correction of an error under Indian Accounting Standard 8.

In contrast, the detailed goodwill note says no option amount had been recognised at March 31, 2026 and the classification remained provisional, subject to final evaluation within the measurement period. The acquisition table supports that presentation because its Rs 4.53 crore goodwill calculation uses only the Rs 5.16 crore cash-and-equity consideration and does not display an option value within consideration transferred.

The supplied disclosures do not reconcile the audit matter with the detailed goodwill note. Readers can therefore identify the disclosed timing difference: the goodwill note describes the reporting position at March 31, 2026, while the audit matter refers to a measurement period that ended later, on June 23, 2026.

How did the acquisition change Rays of Belief’s reported financials?

Rays of Belief moved from standalone reporting for the years ended March 31, 2024 and March 31, 2025 to consolidated reporting for the year ended March 31, 2026. Consolidation began from June 23, 2025 because Rays of Belief acquired 100% of Mom's Belief US Inc. and, indirectly, 100% of Allergy & Immunology LLC.

Consolidated revenue from operations was Rs 81.66 crore in the year ended March 31, 2026, compared with standalone revenue of Rs 36.42 crore in the year ended March 31, 2025. Consolidated profit before tax was Rs 6.90 crore, against standalone profit before tax of Rs 0.35 crore in the preceding year, although the periods are not directly comparable because the US businesses were consolidated only from the acquisition date.

The acquisition added Rs 5.37 crore of right-of-use assets, which represent rights to use leased assets, and Rs 2.11 crore of gross property, plant and equipment from the US subsidiary. The acquired entity also brought Rs 1.31 crore of cash and cash equivalents into the group at June 23, 2025, while Rays of Belief ended March 31, 2026 with Rs 3.26 crore of consolidated cash and cash equivalents.

Conclusion

Rays of Belief’s US acquisition had Rs 5.16 crore of recognised cash and equity consideration at March 31, 2026, producing Rs 4.53 crore of acquisition-date goodwill before translation differences. A further Rs 7.74 crore of stock options remained ungranted because all options were linked to three-year EBITDA targets rather than time served or completion of the transaction.

The next disclosure to watch is Rays of Belief’s conclusion on whether the option component is contingent acquisition consideration or remuneration for post-combination services. The key audit matter says the measurement period ended on June 23, 2026 and the purchase-price allocation was finalised, while the March 31, 2026 goodwill note says the classification remained under evaluation.